NCT02770872
- Conditions
- Cardiovascular Disease, Cardiovascular Diseases, Dyslipidemias, +6 more
- Locations
-
- VA Medical Center Lexington, Kentucky, United States
Clinical trial condition
Dyslipidemias
Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.
948 public trials
78 recruiting studies
Dyslipidemias trial results
NCT01350843
- Conditions
- Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemia, +22 more
- Locations
-
- David Greenfield Human Physiology Unit, University of Nottingham Nottingham, Notts, United Kingdom
NCT01105975
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Diego, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Spring Valley, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vista, California, United States
Completed
Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia
NCT02304926
- Conditions
- Dyslipidemia, Dyslipidemias, Inflammation, +5 more
- Locations
-
Not specified
NCT01163851
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Premier Research Group, Limited Peoria, Arizona, United States
- Dedicated Phase 1, Inc. Phoenix, Arizona, United States
- Premier Research Group Limited Phoenix, Arizona, United States
- Vince and Associates Clinical Research Overland Park, Kansas, United States
NCT03210532
- Conditions
- Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
- Locations
-
- Sevrance Hospital Seoul, South Korea
Completed
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
NCT02207634
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Huntsville, Alabama, United States
- Research Site Mobile, Alabama, United States
- Research Site Glendale, Arizona, United States
NCT00734032
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +6 more
- Locations
-
- GSK Investigational Site Fukuoka, Japan
- GSK Investigational Site Fukuoka, Japan
- GSK Investigational Site Fukuoka, Japan
- GSK Investigational Site Tokyo, Japan
NCT02343497
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Centre Nutrition Clinique Naturalpha Lille, France
NCT03382756
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Dong-A University Hospital Busan, Seo-gu, South Korea